Broken Again. A National Advocate for Drug Recovery Relapses.news2024-09-07T09:00:36+00:00September 7th, 2024|The New York Times|
FDA Declines to Approve MDMA Therapy, and Seeks Further Studynews2024-08-10T11:56:53+00:00August 10th, 2024|The New York Times|
Veterans and Lawmakers Lobby for Approval of MDMA Therapynews2024-08-08T22:01:37+00:00August 8th, 2024|The New York Times|
FDA Panel Rejects Use of MDMA for Treatment of PTSDnews2024-06-04T23:06:17+00:00June 4th, 2024|The New York Times|
Why PTSD Is So Hard to Diagnose and Treatnews2024-06-04T22:00:17+00:00June 4th, 2024|The New York Times|
FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flawsnews2024-05-31T19:08:30+00:00May 31st, 2024|The New York Times|
Lo que hay que saber sobre la ibogaínanews2024-03-09T10:02:51+00:00March 9th, 2024|The New York Times|
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapynews2024-03-05T18:32:51+00:00March 5th, 2024|The New York Times|
What to Know About Ibogaine, a Psychedelicnews2024-03-05T08:00:07+00:00March 5th, 2024|The New York Times|
Gene Therapies Could Transform Rare Diseases. Are We Holding Them Back?news2024-02-19T22:47:36+00:00February 19th, 2024|The New York Times|
